Parallax Volatility Advisers, L.P. Ironwood Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $532 - $988	64 New	64 $0
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $1.46 Million - $3.02 Million	-187,200 Reduced 99.71%	543 $6,000
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $135,615 - $167,269	9,477 Added 5.32%	187,743 $3.47 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $1.54 Million - $2.1 Million	129,900 Added 268.58%	178,266 $3.41 Million
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $203,679 - $249,429	-18,300 Reduced 27.45%	48,366 $746,000
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $335,008 - $401,679	-27,550 Reduced 29.24%	66,666 $999,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $1.14 Million - $1.4 Million	94,216	94,216 $1.49 Million

231

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $322M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.